Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This marks the first time a biosimilar of liraglutide has been introduced in India, following approval from the Drug Controller General of India (DCGI)
The journey with GLP-1s is a marathon, not a sprint
Meanwhile sales of Saxenda, which peaked at 10.7 billion kroner ($1.6 billion) in 2022, fell to roughly $300 million in the first half of this year.
In addition, a selective GIP agonist showed very low effectiveness in reducing weight, while this co-agonist showed synergism in reducing fat mass in obese rodents
Depth of evidence is where tesamorelin stands apart: it carries multiple randomized controlled trials and an FDA approval, whereas ipamorelin remains a research compound with primarily preclinical data, and sermorelin sits between them with older clinical history
